Elizabeth Choe Yu, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 3 carriers
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yu’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A98625 · Current
Licensed to practise in California · since 2007 · expires 2028-08-31 · State University of New York Health Science Center at Brooklyn.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$34,421
Medicare paid this office $34,421 for 539 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 242 | $13,159 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,027 | $103 |
| Critical care, first 30-74 minutes | 12 | $3,338 | $176 |
| Return visit (30+ min) | 37 | $2,907 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,814 | $117 |
See all 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 242 | $13,159 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,027 | $103 |
| Critical care, first 30-74 minutes | 12 | $3,338 | $176 |
| Return visit (30+ min) | 37 | $2,907 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,814 | $117 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 163 | $1,262 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 43 | $690 | $16 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $619 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 43 | $452 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $193 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $138 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $87 | $5 |
Who their Medicare patients are
539 Original Medicare patients in 2024. Average age 73 · Under 65 15% · 85 and older 18% · Women 51% · Also on Medicaid 78% · Health risk score 2.33. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 49% · Coronary heart disease 45% · Heart failure 43% · Atrial fibrillation 37% · Chronic kidney disease 35% · Depression 25% · COPD 20% · Dementia 19% · Stroke 16% · Cancer 15%.
The office billed $433,050, Medicare allowed $48,051 and paid $34,421; for 763 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 539 | 763 | 73 | 2.33 | $433,050 | $34,421 |
| 2023 | 536 | 818 | 73 | 2.30 | $419,923 | $37,061 |
| 2022 | 635 | 925 | 73 | 2.09 | $423,337 | $40,299 |
| 2021 | 753 | 1,130 | 73 | 2.32 | $449,370 | $45,711 |
| 2020 | 693 | 1,098 | 72 | 2.55 | $430,772 | $47,099 |
| 2019 | 850 | 1,272 | 71 | 2.31 | $525,313 | $47,111 |
| 2016 | 484 | 721 | 71 | 2.27 | $227,363 | $26,596 |
| 2015 | 356 | 476 | 69 | 2.11 | $183,055 | $22,717 |
| 2014 | 182 | 215 | 71 | 1.61 | $88,475 | $11,801 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $12,226 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $7,171 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,868 | $119 |
| Return visit (30+ min) | 52 | $3,997 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 139 | $1,159 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 54 | $851 | $16 |
| Short return visit (20+ min) | 17 | $732 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 54 | $581 | $11 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 21 | $455 | $21 |
| Ultrasound of heart, follow-up | 13 | $298 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $215 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $142 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 16 | $67 | $4 |
2022: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 220 | $13,582 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $7,889 | $114 |
| Critical care, first 30-74 minutes | 13 | $4,999 | $238 |
| Return visit (30+ min) | 27 | $2,626 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 251 | $1,948 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,750 | $109 |
| Short return visit (20+ min) | 18 | $945 | $50 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $924 | $84 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 49 | $625 | $13 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $466 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $463 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 49 | $439 | $9 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $311 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 30 | $114 | $4 |
2021: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 233 | $14,698 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $8,375 | $116 |
| Return visit (30+ min) | 30 | $3,643 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 361 | $3,214 | $7 |
| Telephone medical discussion with physician, 21-30 minutes | 30 | $2,490 | $78 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $2,326 | $106 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $788 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 39 | $559 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 39 | $390 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $285 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 43 | $254 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $192 | $10 |
2020: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 211 | $14,199 | $66 |
| Critical care, first 30-74 minutes | 13 | $7,694 | $248 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,527 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 330 | $2,967 | $7 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $2,692 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,582 | $143 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $2,355 | $112 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $1,202 | $38 |
| Return visit (30+ min) | 24 | $1,115 | $45 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 29 | $800 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $632 | $17 |
| Telephone medical discussion with physician, 5-10 minutes | 24 | $525 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $436 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $230 | $11 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $154 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 33 | $142 | $4 |
2019: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 234 | $15,167 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,293 | $93 |
| Return visit (30+ min) | 79 | $6,325 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,727 | $124 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 400 | $3,633 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,095 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 51 | $922 | $18 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 25 | $739 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 51 | $619 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $558 | $6 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 25 | $389 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 25 | $261 | $10 |
2016: 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $9,838 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,572 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,340 | $63 |
| Return visit (30+ min) | 25 | $1,922 | $64 |
| Short return visit (20+ min) | 54 | $1,679 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 163 | $1,427 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 55 | $961 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 57 | $614 | $10 |
| Ultrasound of heart, follow-up | 11 | $250 | $23 |
2015: 6 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 214 | $11,910 | $55 |
| Short return visit (20+ min) | 68 | $4,030 | $42 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,798 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,781 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 56 | $706 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $649 | $19 |
2014: 4 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 120 | $6,947 | $57 |
| Return visit (30+ min) | 30 | $2,168 | $70 |
| Short return visit (20+ min) | 33 | $1,865 | $45 |
| Ultrasound of heart, follow-up | 12 | $299 | $23 |
Medicaid work
$14,887 in 2024
Medicaid paid $14,887 for 1,957 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 677 | $10,188 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 511 | $1,959 |
| CARDIOVASCULAR STRESS TEST | 237 | $1,529 |
| CARDIOVASCULAR STRESS TEST | 237 | $958 |
| Return visit (30+ min) | 14 | $253 |
| Medication list documented in medical record (COA) | 123 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 107 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 24 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 27 | $0 |
| 2024 | 1,957 | 9 | 99 | $14,887 |
| 2023 | 1,841 | 6 | 80 | $14,049 |
| 2022 | 1,763 | 5 | 107 | $15,803 |
| 2021 | 2,249 | 6 | 129 | $17,810 |
| 2020 | 1,539 | 6 | 79 | $13,552 |
| 2019 | 2,106 | 6 | 117 | $12,723 |
| 2018 | 2,307 | 6 | 117 | $18,631 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 694 | $9,389 |
| CARDIOVASCULAR STRESS TEST | 289 | $1,738 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 481 | $1,430 |
| CARDIOVASCULAR STRESS TEST | 289 | $1,062 |
| Return visit (30+ min) | 74 | $430 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 14 | $0 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 526 | $9,299 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 761 | $3,608 |
| CARDIOVASCULAR STRESS TEST | 222 | $1,566 |
| CARDIOVASCULAR STRESS TEST | 222 | $982 |
| Return visit (30+ min) | 32 | $348 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 634 | $10,839 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,271 | $5,494 |
| CARDIOVASCULAR STRESS TEST | 145 | $713 |
| CARDIOVASCULAR STRESS TEST | 145 | $454 |
| Return visit (30+ min) | 41 | $247 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 13 | $63 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 473 | $9,216 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 843 | $3,389 |
| CARDIOVASCULAR STRESS TEST | 89 | $421 |
| CARDIOVASCULAR STRESS TEST | 89 | $246 |
| Return visit (30+ min) | 29 | $175 |
| Short return visit (20+ min) | 16 | $105 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 518 | $6,603 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,080 | $3,364 |
| CARDIOVASCULAR STRESS TEST | 208 | $1,120 |
| CARDIOVASCULAR STRESS TEST | 208 | $706 |
| Return visit (30+ min) | 77 | $589 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 15 | $342 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 475 | $9,670 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,268 | $5,114 |
| CARDIOVASCULAR STRESS TEST | 224 | $1,568 |
| CARDIOVASCULAR STRESS TEST | 224 | $1,006 |
| Return visit (30+ min) | 101 | $722 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 15 | $551 |
Drugs they prescribed that Part D paid
$113,379
Pharmacies billed $113,379 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 877) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
707 generic and 170 brand-name prescriptions · $113,379 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 90 | $58,826 | $654 |
| Jardiance | 31 | $37,924 | $1,223 |
| Entresto | 12 | $9,144 | $762 |
| Metoprolol | 109 | $1,756 | $16 |
| Isosorbide Dinitrate | 23 | $1,037 | $45 |
See all 19 drugs
| Eliquis | 90 | $58,826 | $654 |
| Jardiance | 31 | $37,924 | $1,223 |
| Entresto | 12 | $9,144 | $762 |
| Metoprolol | 109 | $1,756 | $16 |
| Isosorbide Dinitrate | 23 | $1,037 | $45 |
| Atorvastatin | 102 | $896 | $9 |
| Metoprolol | 97 | $292 | $3 |
| Furosemide | 62 | $282 | $5 |
| Hydralazine | 38 | $270 | $7 |
| Nitroglycerin | 29 | $235 | $8 |
| Amlodipine Besylate | 50 | $235 | $5 |
| Losartan | 38 | $211 | $6 |
| Carvedilol | 52 | $192 | $4 |
| Isosorbide Mononitrate Er | 11 | $162 | $15 |
| Lisinopril | 32 | $147 | $5 |
| Propranolol | 12 | $137 | $11 |
| Rosuvastatin | 14 | $117 | $8 |
| Clopidogrel | 11 | $81 | $7 |
| Spironolactone | 14 | $55 | $4 |
Year by year
| 2024 | 877 | 137 | 0% (0) | 19% | $113,379 |
| 2023 | 998 | 134 | 0% (0) | 22% | $164,824 |
| 2022 | 964 | 136 | 0% (0) | 20% | $106,064 |
| 2021 | 953 | 143 | 0% (0) | 22% | $76,778 |
| 2020 | 989 | 131 | 0% (0) | 24% | $67,550 |
| 2019 | 1,036 | 160 | 0% (0) | 18% | $47,738 |
| 2018 | 1,316 | 163 | 0% (0) | 16% | $47,038 |
| 2017 | 1,046 | 148 | 0% (0) | 19% | $32,134 |
| 2016 | 898 | 123 | 0% (0) | None | $38,505 |
| 2015 | 584 | 74 | 0% (0) | None | $15,457 |
| 2014 | 140 | 40 | 0% (0) | 19% | $4,770 |
| 2013 | 32 | 24 | None | None | $828 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Eliquis | 107 | $68,491 | $640 |
| Jardiance | 34 | $46,101 | $1,356 |
| Entresto | 14 | $11,801 | $843 |
| Xarelto | 14 | $9,206 | $658 |
| Atorvastatin | 106 | $3,592 | $34 |
| Metoprolol | 132 | $3,244 | $25 |
| Isosorbide Dinitrate | 29 | $2,361 | $81 |
| Isosorbide Mononitrate Er | 26 | $1,071 | $41 |
| Losartan | 48 | $1,002 | $21 |
| Metoprolol | 82 | $920 | $11 |
| Hydralazine | 47 | $623 | $13 |
| Nitroglycerin | 31 | $613 | $20 |
| Clopidogrel | 26 | $576 | $22 |
| Carvedilol | 64 | $542 | $8 |
| Amlodipine Besylate | 43 | $539 | $13 |
| Furosemide | 57 | $465 | $8 |
| Lisinopril | 26 | $368 | $14 |
| Spironolactone | 11 | $241 | $22 |
2022: 19 drugs
| Eliquis | 60 | $30,795 | $513 |
| Xarelto | 44 | $25,721 | $585 |
| Jardiance | 24 | $17,724 | $739 |
| Entresto | 12 | $5,206 | $434 |
| Diltiazem 12hr Er | 12 | $2,725 | $227 |
| Metoprolol | 150 | $2,512 | $17 |
| Isosorbide Dinitrate | 29 | $2,488 | $86 |
| Atorvastatin | 110 | $2,188 | $20 |
| Nitroglycerin | 50 | $775 | $15 |
| Isosorbide Mononitrate Er | 26 | $658 | $25 |
| Clopidogrel | 36 | $647 | $18 |
| Losartan | 54 | $605 | $11 |
| Carvedilol | 39 | $599 | $15 |
| Metoprolol | 62 | $469 | $8 |
| Fosinopril | 13 | $430 | $33 |
| Furosemide | 71 | $404 | $6 |
| Amlodipine Besylate | 24 | $297 | $12 |
| Hydralazine | 24 | $295 | $12 |
| Lisinopril | 44 | $161 | $4 |
2021: 18 drugs
| Eliquis | 62 | $30,947 | $499 |
| Xarelto | 35 | $24,607 | $703 |
| Entresto | 11 | $4,425 | $402 |
| Diltiazem 12hr Er | 13 | $2,857 | $220 |
| Metoprolol | 121 | $2,099 | $17 |
| Atorvastatin | 128 | $2,014 | $16 |
| Isosorbide Dinitrate | 21 | $1,681 | $80 |
| Nitroglycerin | 34 | $949 | $28 |
| Isosorbide Mononitrate Er | 56 | $877 | $16 |
| Furosemide | 127 | $751 | $6 |
| Sildenafil Citrate | 13 | $721 | $55 |
| Carvedilol | 91 | $715 | $8 |
| Amlodipine Besylate | 28 | $406 | $14 |
| Losartan | 41 | $385 | $9 |
| Metoprolol | 38 | $282 | $7 |
| Clopidogrel | 26 | $278 | $11 |
| Hydralazine | 16 | $247 | $15 |
| Lisinopril | 26 | $127 | $5 |
2020: 16 drugs
| Xarelto | 40 | $29,878 | $747 |
| Eliquis | 47 | $21,969 | $467 |
| Atorvastatin | 148 | $2,032 | $14 |
| Metoprolol | 97 | $1,716 | $18 |
| Isosorbide Dinitrate | 25 | $1,473 | $59 |
| Isosorbide Mononitrate Er | 90 | $1,123 | $12 |
| Nitroglycerin | 32 | $827 | $26 |
| Carvedilol | 88 | $495 | $6 |
| Furosemide | 76 | $450 | $6 |
| Amlodipine Besylate | 63 | $348 | $6 |
| Losartan | 38 | $326 | $9 |
| Hydralazine | 27 | $283 | $10 |
| Metoprolol | 60 | $281 | $5 |
| Clopidogrel | 29 | $277 | $10 |
| Rosuvastatin | 13 | $93 | $7 |
| Lisinopril | 23 | $63 | $3 |
2019: 20 drugs
| Xarelto | 25 | $23,335 | $933 |
| Atorvastatin | 136 | $2,177 | $16 |
| Metoprolol | 77 | $2,023 | $26 |
| Bumetanide | 19 | $1,832 | $96 |
| Isosorbide Mononitrate Er | 96 | $1,550 | $16 |
| Nitroglycerin | 56 | $1,310 | $23 |
| Isosorbide Dinitrate | 20 | $892 | $45 |
| Furosemide | 101 | $816 | $8 |
| Hydralazine | 33 | $608 | $18 |
| Carvedilol | 72 | $597 | $8 |
| Clopidogrel | 28 | $492 | $18 |
| Metoprolol | 84 | $438 | $5 |
| Amlodipine Besylate | 59 | $352 | $6 |
| Potassium Chloride | 17 | $347 | $20 |
| Digoxin | 11 | $341 | $31 |
| Losartan | 29 | $263 | $9 |
| Spironolactone | 21 | $245 | $12 |
| Pravastatin | 11 | $236 | $21 |
| Lisinopril | 25 | $183 | $7 |
| Benazepril | 11 | $183 | $17 |
2018: 22 drugs
| Ranexa | 24 | $8,766 | $365 |
| Eliquis | 15 | $6,288 | $419 |
| Aspirin-Dipyridamole Er | 13 | $4,883 | $376 |
| Isosorbide Dinitrate | 26 | $2,004 | $77 |
| Atorvastatin | 127 | $1,819 | $14 |
| Nitroglycerin | 73 | $1,690 | $23 |
| Isosorbide Mononitrate Er | 96 | $1,579 | $16 |
| Metoprolol | 70 | $1,530 | $22 |
| Hydralazine | 62 | $997 | $16 |
| Potassium Chloride | 44 | $934 | $21 |
| Carvedilol | 88 | $692 | $8 |
| Furosemide | 123 | $634 | $5 |
| Metoprolol | 172 | $621 | $4 |
| Clopidogrel | 39 | $536 | $14 |
| Fosinopril | 29 | $478 | $16 |
| Amlodipine Besylate | 67 | $320 | $5 |
| Pravastatin | 21 | $302 | $14 |
| Propafenone | 12 | $226 | $19 |
| Lisinopril | 63 | $183 | $3 |
| Benazepril | 14 | $152 | $11 |
| Losartan | 23 | $125 | $5 |
| Spironolactone | 23 | $103 | $4 |
2017: 21 drugs
| Ranexa | 22 | $8,012 | $364 |
| Aspirin-Dipyridamole Er | 11 | $4,012 | $365 |
| Atorvastatin | 117 | $1,642 | $14 |
| Isosorbide Dinitrate | 23 | $1,540 | $67 |
| Nitroglycerin | 61 | $1,485 | $24 |
| Isosorbide Mononitrate Er | 71 | $1,007 | $14 |
| Hydralazine | 67 | $998 | $15 |
| Metoprolol | 46 | $920 | $20 |
| Metoprolol | 161 | $563 | $3 |
| Flecainide Acetate | 11 | $449 | $41 |
| Potassium Chloride | 26 | $444 | $17 |
| Carvedilol | 85 | $440 | $5 |
| Fosinopril | 27 | $333 | $12 |
| Lisinopril | 64 | $325 | $5 |
| Furosemide | 81 | $267 | $3 |
| Clopidogrel | 22 | $242 | $11 |
| Propafenone | 11 | $233 | $21 |
| Amlodipine Besylate | 35 | $194 | $6 |
| Hydrochlorothiazide | 12 | $100 | $8 |
| Simvastatin | 12 | $76 | $6 |
| Spironolactone | 11 | $61 | $6 |
2016: 20 drugs
| Ranexa | 13 | $4,134 | $318 |
| Isosorbide Dinitrate | 33 | $2,911 | $88 |
| Atorvastatin | 95 | $1,904 | $20 |
| Isosorbide Mononitrate Er | 60 | $911 | $15 |
| Metoprolol | 34 | $831 | $24 |
| Nitrostat | 18 | $775 | $43 |
| Potassium Chloride | 13 | $451 | $35 |
| Metoprolol | 124 | $448 | $4 |
| Hydralazine | 35 | $435 | $12 |
| Carvedilol | 70 | $372 | $5 |
| Fosinopril | 25 | $287 | $11 |
| Furosemide | 50 | $284 | $6 |
| Lisinopril | 77 | $274 | $4 |
| Propafenone | 12 | $269 | $22 |
| Clopidogrel | 19 | $259 | $14 |
| Losartan | 45 | $241 | $5 |
| Amlodipine Besylate | 29 | $214 | $7 |
| Simvastatin | 22 | $168 | $8 |
| Hydrochlorothiazide | 26 | $135 | $5 |
| Spironolactone | 13 | $95 | $7 |
2015: 16 drugs
| Isosorbide Dinitrate | 27 | $3,182 | $118 |
| Atorvastatin | 103 | $2,083 | $20 |
| Nitrostat | 18 | $783 | $43 |
| Isosorbide Mononitrate Er | 46 | $702 | $15 |
| Carvedilol | 66 | $385 | $6 |
| Metoprolol | 11 | $307 | $28 |
| Pantoprazole | 18 | $298 | $17 |
| Clopidogrel | 19 | $293 | $15 |
| Losartan | 30 | $246 | $8 |
| Furosemide | 50 | $216 | $4 |
| Metoprolol | 42 | $209 | $5 |
| Amlodipine Besylate | 16 | $136 | $8 |
| Lisinopril | 28 | $132 | $5 |
| Fosinopril | 12 | $126 | $10 |
| Hydrochlorothiazide | 15 | $117 | $8 |
| Simvastatin | 14 | $89 | $6 |
2014: 2 drugs
| Atorvastatin | 16 | $404 | $25 |
| Carvedilol | 13 | $145 | $11 |
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Shire North American Group Inc · Continuation Study With Budesonide Oral Suspension Bos for Adolescent and Adult Subjects With Eosinophilic Esophagitis Eoe · 2019 | Their institution | $20,523 |
| Takeda Pharmaceuticals U.S.A., Inc. · Oral Budesonide Suspension (Obs) in Adolescents and Adult Subjects With Eosinophilic Esophagitis: Db, Maintenance · 2020 | Their institution | $11,211 |
| Shire North American Group Inc · Oral Budesonide Suspension Obs in Adolescents and Adult Subjects With Eosinophilic Esophagitis Db, Maintenance · 2019 | Their institution | $4,349 |
| Takeda Pharmaceuticals U.S.A., Inc. · Oral Budesonide Suspension (Obs) in Adolescents and Adult Subjects With Eosinophilic Esophagitis: Db, Placebo-Controlled, Rw · 2020 | Their institution | $2,809 |
| Shire North American Group Inc · Oral Budesonide Suspension Obs in Adolescents and Adult Subjects With Eosinophilic Esophagitis Db, Placebo-Controlled, Rw · 2019 | Their institution | $2,085 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346459179
- Licence
- CA A98625California A98625: Current · expires 2028-08-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 1321 Rimrock Dr, San Jose, CA, 95120
- NPI first listed
- 2007-05-21
- NPI last updated
- 2014-11-05
This is when the NPI record was last certified, not a medical board exam.